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Abstract
Background: RD-114 virus is a feline endogenous retrovirus and produced as infectious viruses in some feline cell
lines. Recently, we reported the contamination of an infectious RD-114 virus in a proportion of live attenuated
vaccines for dogs and cats. It is very difficult to completely knock out the RD-114 proviruses from cells, as
endogenous retroviruses are usually integrated multiply into the host genome. However, it may be possible to
reduce the risk of contamination of RD-114 virus by regulating the viral release from cells.
Results: In this study, to understand the molecular mechanism of RD-114 virus budding, we attempted to identify
the viral and cellular requirements for RD-114 virus budding. Analyses of RD-114 L-domain mutants showed that
the PPPY sequence in the pp15 region of Gag plays a critical role in RD-114 virus release as viral L-domain.
Furthermore, we investigated the cellular factors required for RD-114 virus budding. We demonstrated that RD-114
virus release was inhibited by overexpression of dominant negative mutants of Vps4A, Vps4B, and WWP2.
Conclusions: These results strongly suggest that RD-114 budding utilizes the cellular multivesicular body sorting
pathway similar to many other retroviruses.
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Background
The cat genome contains an infectious endogenous ret-
rovirus (ERV), named RD-114 virus [1-3]. The RD-114
virus is a recombinant comprised of the gag-pol genes
from a gammaretrovirus and the env gene from a betar-
etrovirus [4]. The amounts of viral RNA reach approxi-
mately 100 copies per cells in feline cells [3]. Some
feline cell lines, such as Crandell-Rees feline kidney
(CRFK) cells, constitutively express infectious RD-114
virus [5,6]. These cells have been used to grow several
live attenuated vaccines for cats and dogs. Recently, we
reported the isolation of an infectious RD-114 virus in a
proportion of live attenuated vaccines for pets [7-9].
RD-114 is a polytropic virus and has potential risks in
that interspecies transmission may induce unpredictable
diseases, although the pathogenicity of RD-114 has not
been demonstrated [5]. However, it is very difficult to
completely exclude the proviral DNA of RD-114 from
cells, as ERVs are usually integrated into multiple loci of
the host chromosomes. Therefore, it may be a practical
strategy to reduce the risk of contamination of RD-114
virus by regulating the release of infectious RD-114
from cells.
It is unknown how RD-114 virus buds from the
plasma membrane of infected cells. Gag proteins of
many retroviruses include short peptide motifs required
for virus budding, i.e., L-domains. To date, three types
of L-domain motif have been identified: PT/SAP, PPxY,
and YxxL [10]. The PTAP motif interacts with Tsg101,
an ubiquitin-conjugating E2 enzyme variant (UEV) and
the PPxY motif interacts with Nedd4-like E3 ubiquitin
ligases [11-16]. The cellular factor that interacts with
the YxxL motif has been shown to be AIP1/Alix [17].
These host factors are the cellular proteins involved in
the multivesicular body (MVB) sorting pathway. The
MVB complex consists of a network of class E vacuolar
protein sorting proteins, which form four distinct het-
eromeric endosomal sorting complexes required for
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transport known as ESCRT (endosomal sorting com-
plexes required for transport)-0, -I, -II, and -III; these
four complexes are required for the formation and
release of the vesicles of the MVB [11,17-20]. Their
major function in the cell is to transport cargo proteins,
such as activated cell surface receptors, from the early
endosomal membrane to be released into the lysosome
in small vesicles for degradation. The proteins are tar-
geted to the endosomal degradation pathway by modifi-
cation with mono- to tetraubiquitin chains. The
components of ESCRT complexes participate in inward
invagination and budding of late endosomal membranes
to form MVB. Therefore, the processes of virus budding
and MVB vesicle budding are considered fundamentally
the same, although they occur at different sites in the
cell. The ESCRT machinery is processed by sequential
interaction of target protein with ESCRT-0, -I, -II, and
-III [21]. Vps4 is an AAA ATPase and performs a key
function in this pathway by recognizing membrane-asso-
ciated ESCRT-III assemblies and catalyzing their disas-
sembly, possibly in conjunction with membrane fission.
It has been reported that abrogations of the functions of
these cellular factors using dominant-negative mutants
or siRNA inhibit viral release of various enveloped
viruses possessing L-domains.
In this study, to obtain the information useful for the
inhibition of RD114 release from cells, we analyzed the
molecular mechanism of RD-114 virus budding.
Results
The PPPY sequence functions as a major L-domain in RD-
114 replication
To examine the functions of two putative L-domain
motifs in the pp15 region of RD-114 Gag, PSAP and
PPPY, we constructed expression plasmids for the RD-
114 mutants, which substituted PSAP, PPPY, or both
sequences to all alanine, AAAA (Figure 1A). The
expression plasmids for wild-type (WT) or mutant RD-
114 were transfected into 293 T cells. At 72 h posttrans-
fection, the amounts of the intracellular Gag precursor
(Pr68) and the capsid protein (p28CA) in virus particles
were analyzed by Western blotting using anti-RD-114
Gag antibodies. As shown in Figure 1B, similar levels of
Gag precursor were synthesized in cells expressing
either WT or mutant genomes. The release of virus par-
ticles into the medium was greatly reduced by alanine
substitution of the PPPY motif, while the PSAP muta-
tion had no apparent effect on virus production. More-
over, the AAAA/AAAA mutant with the mutation
introduced into both L-domain motifs, PSAP and PPPY,
showed the reduction of virus release as well as the
PSAP/AAAA mutant. The levels of virus production of
mutants were also quantitatively analyzed by real-time
RT-PCR targeting the pol region (Figure 1C). The
progeny virus production of the PSAP/AAAA mutant or
the AAAA/AAAA mutant was only 5.9% or 5.5% of that
of WT, respectively (p < 0.01), while the AAAA/PPPY
mutant produced progeny virion at the similar level to
WT. Thus, the results of real-time RT-PCR were consis-
tent with those of Western blotting analysis. These data
suggest that the PPPY motif, but not the PSAP motif,
plays a major role as an L-domain in RD-114 budding.
RD-114 production is inhibited by overexpression of the
dominant-negative mutant of WWP2
It has been reported that the PPxY sequence identified
as a viral L-domain in various viruses interacts with the
WW domains of the cellular Nedd4-like E3 ubiquitin
ligases [13,15]. This interaction is essential for the func-
tion of the PPxY L-domain motif in virus budding,
although the precise role of Nedd4-like E3 ubiquitin
ligases in virus budding has not been clarified. To exam-
ine the involvement of Nedd4-like E3 ubiquitin ligases
in the egress of RD-114, the RD-114 infectious clone,
pTERD-114, was cotransfected with plasmids directing
expression of the dominant-negative mutants of Nedd4,
Nedd4L, BUL1, WWP2, and Smurf2, Nedd4-WW,
Nedd4L-WW, BUL1-WW, WWP2-WW, and Smurf2-
WW, which express only WW domains, into 293 T
cells and monitored for impact on RD-114 virus
Figure 1 Identification of the L-domain, which is critical for RD-
114 virus budding. (A) Schematic representation of RD-114 Gag
and the L-domain mutants. The positions of the two putative L-
domain motifs are indicated. (B and C) 293 T cells were transfected
with the RD-114 infectious clone for wild-type (pTERD-114) or the L-
domain mutant (0.5 μg). Cells and viruses were collected at 72 h
after transfection, and analyzed by Western blotting (B) and real-
time RT-PCR targeting the pol region (C). The virus production from
cells expressing wild-type (WT) RD-114 was set to 100%. The data
are shown as averages and standard deviations of 3 independent
experiments. Statistical analysis was performed by using the
Student’s t-test (*: p < 0.01)
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production by Western blotting and real-time RT-PCR
as in Figure 1. As shown in Figure 2A, virus production
was significantly reduced to 2% of control by overex-
pression of WWP2-WW (p < 0.01). The effects of these
WW domains of the cellular Nedd4-like E3 ubiquitin
ligases were also investigated in CRFK cells, which is a
feline cell line constitutively expressing infectious endo-
genous RD-114. The analysis was performed by real-
time RT-PCR as it was difficult to detect the low levels
of RD-114 virus production from CRFK cells by Wes-
tern blotting (Figure 2B). It was shown that WWP2-
WW also significantly inhibited the production of endo-
genous RD-114 expression to 1% of control in CRFK
cells. These results suggest that WWP2 or another
HECT E3 ubiquitin ligase closely related to WWP2 is
involved in RD-114 budding.
RD-114 budding depends on ESCRT machinery
Identification of functional L-domain in RD-114 Gag
and the involvement of Nedd4-like E3 ubiquitin ligase
in RD-114 budding strongly suggest that RD-114 utilizes
the ESCRT machinery in its budding similar to many
other enveloped viruses [10]. It has been reported that
overexpression of the ATPase-deficient mutant of
Vps4A or Vps4B, Vps4AE228Q or Vps4BE235Q,
inhibited the release of a unique subset of ESCRT-utiliz-
ing retroviruses depending on L-domain differences in a
dominant-negative manner [11]. To determine whether
RD-114 virus budding utilizes the ESCRT machinery,
293 T cells were cotransfected with the plasmid for
Vps4AE228Q or Vps4BE235Q along with pTERD-114.
At 72 h posttransfection, viral protein synthesis and vir-
ion release were analyzed by Western blotting and real-
time RT-PCR as shown in Figure 1. We observed that
virus release was significantly reduced to 4.4% or 15%,
respectively, by the overexpression of Vps4AEQ or
Vps4BEQ (p < 0.01) (Figure 3A). We also analyzed the
effects of Vps4AE228Q or Vps4BE235Q overexpression
in CRFK cells (Figure 3B). The virus release of RD-114
endogenously expressed in CRFK cells was also inhibited
by the overexpression of Vps4AE228Q or Vps4BE235Q,
indicating that RD-114 utilizes the cellular ESCRT
machinery in the budding of progeny viruses.
Discussion
In this study, we demonstrated that the PPPY sequence
in the pp15 region of RD-114 Gag plays a critical role in
virus production as a major L-domain and that WWP2
or WWP2-like E3 ubiquitin ligases possessing the WW
Figure 2 Effects of dominant-negative mutants of Nedd4-like
E3 ubiquitin ligases on RD-114 production. (A) 293 T cells were
cotransfected with pTERD-114 (100 ng) and either the expression
plasmid for the dominant-negative mutants of Nedd4-like E3
ubiquitin ligases, which express only WW domains containing N-
terminal FLAG-tag, or the empty vector pCDNFL (Control) (1 μg).
Cells and viruses were collected at 72 h after transfection, and
analyzed by Western blotting (upper) and real-time RT-PCR (lower).
The virus production in Control was set to 100%. The data are
shown as averages and standard deviations of 3 independent
experiments. (B) CRFK cells were transfected with the expression
plasmid for the dominant-negative mutant of Nedd4-like E3
ubiquitin ligases (1 μg) and analyzed as in (A). Statistical analysis
was performed by using the Student’s t-test (*: p < 0.01)
Figure 3 Inhibition of RD-114 production by overexpression of
the dominant-negative mutants of Vps4A/B. (A) 293 T cells were
cotransfected with pTERD-114 (100 ng) and either the expression
plasmids for Vps4A/B dominant-negative mutant containing N-
terminal FLAG-tag, or the empty vector pCDNFL (Control) (100 ng),
and then analyzed by Western blotting (upper) and real-time RT-
PCR (lower) as in Figure 1. The virus production in Control was set
to 100%. The data are shown as averages and standard deviations
of 3 independent experiments. Statistical analysis was performed by
using the Student’s t-test (*: p < 0.01). (B) CRFK cells were
transfected with the expression plasmids Vps4A/B dominant-
negative mutant (1 μg). Cells and viruses were collected at 72 h
after transfection, and analyzed by Western blotting (upper) and
real-time RT-PCR (lower) as in (A).
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domain closely related to WWP2 and Vps4A/B are
involved in RD-114 budding. These data suggest that
RD-114 Gag recruit the cellular ESCRT machinery
through the interaction of the PPPY L-domain with the
WW domain(s) of WWP2 and progeny virions are
released from cells by utilizing the MVB sorting pathway
similar to many other retroviruses. Therefore, strategies
targeting these cellular proteins might be effective to
suppress endogenous RD-114 production from feline
cells. In fact, overexpression of dominant-negative
mutants of WWP2 and Vps4A/B could markedly inhibit
the production of endogenous RD-114 viruses from
CRFK cells as well as exogenous RD-114 viruses from
293 T cells (Figures 2 and 3).
WWP2 is known to negatively regulate transcriptional
activity of Oct-4, which is a transcription factor critical
in mammalian embryonic development, by promoting
ubiquitination of Oct-4 [22]. Oct-4 is present in cul-
tured undifferentiated embryonic cell lines, including
embryonic stem (ES) cells, embryonal carcinoma cells,
and embryonic germ cells, while it is absent from all of
the differentiated somatic cell types in vitro and in vivo
[23]. A recent study also showed that WWP2 inhibits
activation-induced T-cell death by catalyzing ubiquitina-
tion of EGR2, which is a zinc finger transcription factor
that regulates Fas ligand (FasL) expression [24]. There-
fore, abrogation of WWP2 function by constitutive
expression of dominant-negative mutant may be possi-
ble in most of the differentiated somatic cell lines that
have been used for production of vaccine or biological
substances.
Furthermore, we recently reported that matrix proteins
(VP40) of Ebola and Marburg viruses recognize a differ-
ent WW domain within Nedd4.1, although both VP40
proteins interact with Nedd4.1 via their PPxY L-domain
[25]. WWP2 contains four WW domains [22]. Identifica-
tion of the WW domain that specifically binds to RD-114
Gag may enable the development of strategies that have
minimal effect on physiological function of WWP2 and
efficiently reduce endogenous RD-114 production.
Strategies targeting Vps4 might also be available to
reduce endogenous RD-114 production. Recently, a
stable cell line with inducible expression of a dominant-
negative form of Vps4 has been established [26]. This
method would be applicable to the various cellular fac-
tors the dominant-negative forms of which inhibit RD-
114 production.
Taken together, our data would be useful for develop-
ment of the strategies to control virus production in cells
constitutively producing infectious endogenous viruses.
Conclusions
In this study, we revealed that the PPPY sequence in the
pp15 region of Gag plays a critical role in the virus
budding of RD-114 as viral L-domain. Furthermore, we
demonstrated that RD-114 virus production was signifi-
cantly inhibited by overexpression of dominant-negative
mutants of Vps4A, Vps4B, and WWP2. These results
strongly suggest that RD-114 budding utilizes the MVB
sorting pathway similar to many other retroviruses.
Methods
Cells
Human embryonic kidney (HEK) 293 T cells (ATCC
CRL-11268), and Crandell-Rees feline kidney (CRFK)
cells (ATCC CCL-94) were maintained at 37°C in a 5%
CO2 incubator in Dulbecco’s modified Eagle’s medium
(Sigma, St. Louis, MO) supplemented with 10% fetal
bovine serum and penicillin/streptomycin.
Plasmids
A plasmid containing an intact infectious clone of RD-
114, pTERD-114, was constructed from TE/RD114 cell
[27,28]. To generate the expression plasmids for the
RD-114 L-domain mutants, AAAA/PPPY, PSAP/AAAA,
and AAAA/AAAA (Figure 1A), alanine substitutions
were introduced into pTERD-114 by site-directed muta-
genesis using a KOD-Plus-Mutagenesis Kit (Toyobo,
Osaka, Japan). The expression plasmids for each domi-
nant-negative mutant of Nedd4, BUL1, Vps4A, and
Vps4B: pNedd4-WW (NP_006145, amino acid region
192-506), pBUL1-WW (NP_055867, amino acid region
830-1051), pVps4AE228Q, and pVps4BE235Q, respec-
tively, were constructed previously [15,16,29]. The
expression plasmids for each dominant-negative mutant
of Nedd4L, WWP2, and Smurf2: pNedd4L-WW
(NP_001138442, amino acid region 68-456), pWWP2-
WW (NP_008945, amino acid region 293-485), and
pSmurf2-WW (NP_073576, amino acid region 151-338),
were constructed in this study. Each WW construct of
Nedd4L, WWP2, and Smurf2 was amplified by standard
PCR using primer containing KpnI sites from the
human spleen Marathon-Ready cDNA library (Clontech,
Mountain View, CA). These products were subcloned
into pCDNFL, which was constructed from pcDNA3.1
(Invitrogen, Carlsbad, CA) to express a protein contain-
ing a FLAG-tag at the N terminus.
Production of anti-RD-114 Gag antibody
RD-114 Gag (amino acid residues 225-550) was
expressed in Escherichia coli BL21 as a GST fusion pro-
tein (from pGEX6P-2; GE Healthcare, Piscataway, NJ),
and purified from the bacterial extracts according to the
manufacturer’s instructions. As the GST fusion proteins
attached to the glutathione-Sepharose 4B beads were
digested with PreScission protease (GE Healthcare), the
purified Gag protein did not contain GST. The purified
Gag protein was used to immunize rabbits.
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Western blot analyses
For L-domain mutant analysis, 293 T cells (2 × 105)
were transfected with the expression plasmid for RD-
114 wild-type or L-domain mutant, AAAA/PPPY,
PSAP/AAAA, or AAAA/AAAA, using Trans-IT LT-1
(Mirus Bio Corp., Madison, WI). For analyses of the cel-
lular factors, 293 T or CRFK cells (2 × 105) were
cotransfected with pTERD-114 (100 ng) and pNedd4-
WW, pNedd4L-WW, pBUL1-WW, pWWP2-WW,
pSmurf2-WW, pVps4AE228Q, or pVps4BE235Q (0.1 or
1 μg) using Trans-IT LT-1. At 72 h after transfection,
the supernatants were separated from cell debris by cen-
trifugation (10,000 × g; 15 min) and then virions were
pelleted through a 16.5% sucrose cushion by ultracentri-
fugation (348,000 × g; 40 min at 4°C) [27]. Pelleted vir-
ions were resuspended in PBS(-). Cells were lysed with
lysis A buffer [30]. Cell lysates and virions were analyzed
by Western blotting using anti-RD-114 Gag antibody,
anti-FLAG M2 antibody (Sigma), and anti-actin anti-
body (Sigma) as described previously [27,29,31,32].
Real-time RT-PCR
To quantify the release of progeny virions from cells, vir-
ions were prepared as described in Western blot analyses.
Viral RNAs were extracted from pelleted virions using a
QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA).
After DNaseI treatment, real-time RT-PCR was per-
formed using a One Step SYBR RT-PCR Kit (Takara,
Shiga, Japan). The primers targeting the RD-114 pol
region, 5’-GAGACCCTTACTAAATTGAC-3’ (forward)
and 5’-AGTTTCTGGTCCAGGGGTTT-3’ (reverse),
were used for real-time RT-PCR [33]. The amplification
was carried out in a 25-μl reaction volume and contained
12.5 μl of 2 × One Step SYBR RT-PCR Buffer III, 2.5 U
of TaKaRa Ex Taq HS, 0.5 μl of PrimeScript RT enzyme
Mix II, 5 pmol of forward and reverse primers, and 2 μl
of RNA sample. The thermal profile was at 42°C for 5
min and 95°C for 10 s, followed by 45 cycles of 95°C for
5 s, 60°C for 20 s, and 72°C for 15 s. Thermal cycling
and quantification were performed using a Smart Cycler
II System (Cepheid, Sunnyvale, CA).
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